Gilead

Four Promising Biotech Stocks With Upcoming Catalysts
Minyanville
Thu, 08/22/13 - 10:05 am
GSK
Sarepta
Gilead
sofosbuvir
SGX203
SGX942
Soligenix
drisapersen
Drug Manufacturers Industry: Where Bristol-Myers, Sanofi And Gilead Stand
Seeking Alpha
Wed, 08/14/13 - 09:23 pm
Sanofi
Bristol-Myers Squibb
Gilead
A House Bill Would Change Exclusivity For Some Combo Drugs
Pharmalot
Tue, 08/6/13 - 11:12 am
Gilead
FDA
Bayer
Ferring
Gilead profit rises, shares jump on Vertex hepatitis setback
Reuters
Thu, 07/25/13 - 05:28 pm
earnings
Gilead
Innovations In HIV: Johnson & Johnson, Glaxo Vs. Gilead
Seeking Alpha
Mon, 07/22/13 - 10:26 am
HIV
Atripla
JNJ
Pfizer
GSK
Gilead
Dolutegravir
Edurant
China
TMC310911
Three Future Winners and One Major Loser in the HCV Wars
Motley Fool
Fri, 07/19/13 - 11:38 am
hepatitis C
AbbVie
Bristol-Myers Squibb
Gilead
Idenix
sofosbuvir
ledipasvir
daclatasvir
asunaprevir
BMS-791325
IDX20963
3 Sources Of Revenue For Incyte
Seeking Alpha
Thu, 06/27/13 - 12:51 am
Incyte
Gilead
Eli Lilly
Novartis
Sanofi
Achillion May Be The Most Underrated Biotech Left
Seeking Alpha
Wed, 06/26/13 - 09:35 am
Achillion
AbbVie
Bristol-Myers Squibb
Gilead
Vertex Pharmaceuticals
Indenix
ACH-3102
ACH-1625
hepatitis C
[video]3 Blood Cancer Drug Hopefuls in the Spotlight
Motley Fool
Thu, 06/20/13 - 07:46 am
Infinity Pharmaceuticals
JNJ
Pharmacyclics
Gilead
non-Hodgkin's lymphoma
ibrutinib
Idelalisib
IPI-145
Gilead's Potential Megablockbuster Raises the Bar
Motley Fool
Mon, 06/17/13 - 09:24 am
Gilead
sofosbuvir
hepatitis C
AbbVie says it could beat Gilead to huge market for hep C drugs
Fierce Pharma
Fri, 06/14/13 - 10:34 am
AbbVie
Gilead
hepatitis C
Consider Biotech Gilead Sciences Because Of Atripla, Sofosbuvir And Great R&D
Seeking Alpha
Fri, 06/14/13 - 08:27 am
sofosbuvir
Atripla
Gilead
HIV
R&D
hepatitis C
Inside HCV: An Interview with Janssen
Motley Fool
Thu, 06/13/13 - 10:54 am
hepatitis C
Janssen
Gilead
JNJ
Vertex
simeprevir
sofosbuvir
AIDS drugs halve HIV risk for intravenous drug users in study
Reuters
Wed, 06/12/13 - 12:42 pm
IV drug use
HIV
AIDS
tenofovir
Gilead
Infinity Pharmaceuticals And IPI-145: ASCO 2013 Highlights
Seeking Alpha
Mon, 06/10/13 - 11:00 am
ASCO
Infinity Pharmaceuticals
Gilead
IPI-145
Drugs Go From Hit to Dud in Two Years in Hepatitis Race
Bloomberg
Mon, 06/3/13 - 10:27 am
hepatitis C
Merck
Gilead
Vertex Pharmaceuticals
JNJ
Medivir
Bristol-Myers Squibb
The Race For Oral HCV?
Seeking Alpha
Fri, 05/31/13 - 12:57 pm
AbbVie
Gilead
JNJ
Merck
Vertex Pharmaceuticals
hepatitis C
3 Stocks to Watch Ahead of ASCO
Motley Fool
Tue, 05/28/13 - 06:28 pm
cancer
ASCO
nivolumab
Bristol-Myers Squibb
idelalisad
Gilead
PEGPH20
Halozyme
pancreatic cancer
Gilead Sciences' Move Into Cancer Drugs
Seeking Alpha
Mon, 05/27/13 - 09:50 am
Gilead
Pharmacyclics
blood cancer
leukemia
Gilead's sofosbuvir gets EMA validation, now under assessment
The Fly on the Wall
Wed, 05/22/13 - 10:16 am
Gilead
Europe
sofosbuvir
hepatitis C

Pages